Products and Services: Bone and Mineral


Quidel  is a leading manufacturer of diagnostic healthcare solutions serving to enhance the health and well being of people around the globe with well known and respected products that provide healthcare professionals with accurate and cost-effective diagnostic information at the point of care (POC).


RAPID DIAGNOSTICS


Marketed under the leading brand name of QuickVue, Quidel's portfolio of products currently includes tests that aid in the diagnosis of several disease or condition states, including influenza, RSV, fecal occult blood, Strep A, pregnancy, bacterial vaginosis, infectious mononucleosis, H. pylori, and Chlamydia.


SPG


The Quidel Specialty Products Group identifies, develops, manufactures and markets unique diagnostic and research assays and reagents with applications in oncology, bone health and inflammatory diseases. Our kits and reagents are marketed worldwide under the MicroVue brand.





Quidel's core competencies and capabilities include:

  • Immunoassay development and automated manufacturing
    • Lateral Flow (LF): infectious disease, women's health
    • Direct Fluorescent Antibodies (DFA) : infectious disease, virology
    • Microtiter: bone and complement pathway markers
  • Monoclonal antibody characterization and development
  • Molecular assay development


Quidel commenced operations in 1979 and we launched our first products, dipstick-based pregnancy tests, in 1984. Our product base and technology platforms have expanded through internal development and acquisitions of other products and technologies. The current product areas are infectious diseases, pregnancy, herpes, Graves' Disease, autoimmune diseases and osteoporosis, for professional and research use. During the early 1990's, Quidel successfully embarked on a mission to build its own branded business and market franchises in the professional use markets. As a result, sales are primarily driven by our branded business under the QuickVue® brand name, and the Company enjoys excellent product recognition in its target markets.

In early 2010, the Company acquired Diagnostic Hybrids (DHI) as part of a continued focus on increasing its research and development efforts to accelerate the rate of new product introductions.

The strength of Quidel's brand equity is reflected in the success of QuickVue® in markets around the world. We are extending the QuickVue® brand in select Asian and European markets. We sell through sales representatives for Europe, Middle East, Africa, Asia-Pacific, Latin America and, other international locations, by channeling products through distributor organizations and sales agents. We market our products in the U.S. through a network of national and regional distributors, supported by a direct sales force, and were pleased to be recognized by three of the largest U.S. medical supply distributors as "Supplier of the Year" within the last year.

Immuno - improving life through science


Call us /Toll Free/

AUS 1 800 252 215
NZ 0 800 448 875

Postal contact

PO Box 101
St Peters NSW 2044
Australia